Results 141 to 150 of about 16,250 (229)

Inter-society consensus on the management of acute bloody diarrhea and shiga toxin-producing Escherichia coli infection in the molecular microbiology era. [PDF]

open access: yesItal J Pediatr
Ardissino G   +35 more
europepmc   +1 more source

Silibinin Potentiates Antimicrobial Action and Reduces Staphyloxanthin in <i>Staphylococcus aureus</i>. [PDF]

open access: yesPharmaceuticals (Basel)
Pereira-Filho JL   +13 more
europepmc   +1 more source

Comparative Market Analysis: STX, RBTC

open access: yes
Abstract: Over the past year, RBTC (Rootstock) delivered a near‑doubling of its price (+98.91%) with low volatility (2.35%) and a strong Sharpe Ratio (1.76), positioning it as the clear top performer in the Bitcoin DeFi space. In contrast, STX (Stacks) suffered a steep decline (-47.47%), exhibited high daily volatility (33.24%), and posted a modest ...
openaire   +2 more sources

Shiga toxin increases intestinal transit to displace resident microbes and facilitate pathogen colonization. [PDF]

open access: yesPLoS Pathog
Odem MA   +11 more
europepmc   +1 more source

Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing <i>Escherichia coli</i>-associated hemolytic uremic syndrome: a <i>post hoc</i> analysis of a phase 2 clinical trial. [PDF]

open access: yesJ Clin Microbiol
Landivar SM   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy